Next generation preclinical development (caspase inhibitors, stem cell evaluation) and islet metabolic engraftment efficiency in a Phase I/II clinical study of the Cell Pouch™ for islet transplantation in Type 1 diabetes. (The Cell Pouch System™ is a proprietary non-biodegradable polymer device designed by biologists, scientists and engineers which unobtrusively fits under the skin, rapidly incorporating […]
Read More